US biotech Aktis Oncology has filed IPO documents with the Securities and Exchange Commission (SEC), in what could be the first biotech listing on the Nasdaq in 2026. The Boston-based ...
Cervical cancer incidence has declined close to 30% among women aged 20 to 31 years since the start of the millennium, but certain states have achieved significantly greater reductions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results